AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Islamabad, Citi Pharma Ltd. (CPHL) announced moderate growth amidst market volatility at the Pakistan Stock Exchange (PSE). With a daily weighted average rate of Rs. 2,284.61, the pharmaceutical company continues to navigate through challenging market conditions. CPHL, listed since 2021, reported an EPS of Rs. 2.88 for the year 2022/2023, reflecting its steady performance in the sector. The company, with a paid-up capital of Rs. 27.26 million, did not declare any distributions for the year ending June. Despite market fluctuations, Citi Pharma remains resilient, with a book closure on October 20th and a market lot of 10 shares.
Check Also
Fauji Fertilizer Announces Public Offer to Acquire Control of Agritech Limited
Karachi: Fauji Fertilizer Company Limited has made a public announcement regarding its offer to acquire 151,052,013 ordinary shares of Agritech Limited, in line with the Securities Act, 2015, and the Listed Companies (Substantial Acquisition of Voting...
The post Fauji Fertilizer Announces Public Offer to Acquire Control of Agritech Limited appeared first on .